Opinion

... in response to Advances in influenza research
  1. It seemed that the author intended to avoid mentioning mRNA influenza
    William CHUI William CHUI Hong Kong S.A.R. says:
    July 2, 2023 at 12:08 PM

    It seemed that the author intended to avoid mentioning mRNA influenza vaccine which is in
    Preclinical or Phase 1 clinical trial. As a scientist with credibility, he or she should provide neutral and unbiased information.

    Reply
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback